Diane E. Wilfong Gilead Sciences, Inc. (GILD) insider trading activity

Diane E. Wilfong is Interim Corp Controller & CAO of GILEAD SCIENCES, INC.. Currently has a direct ownership of 46,259 shares of GILD, which is worth approximately $5.47 Million. The most recent transaction as insider was on Jan 26, 2022, when has been sold 2,871 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.3K

1.28% 3M change

44.51% 12M change

Total Value Held $5.47 Million

Diane E. Wilfong Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 26 2022	BUY Grant, award, or other acquisition	-	2,871 Added 10.98%	23,269 Common Stock
Aug 17 2021	SELL Open market or private sale	$986,725 $72.5 p/Share	13,610 Reduced 40.02%	20,398 Common Stock
Aug 17 2021	BUY Exercise of conversion of derivative security	$919,492 $67.56 p/Share	13,610 Added 28.58%	34,008 Common Stock
Aug 10 2021	SELL Payment of exercise price or tax liability	$62,801 $69.24 p/Share	907 Reduced 4.26%	20,398 Common Stock
Aug 10 2021	BUY Exercise of conversion of derivative security	-	2,480 Added 10.43%	21,305 Common Stock
Mar 10 2021	SELL Payment of exercise price or tax liability	$38,921 $63.91 p/Share	609 Reduced 3.13%	18,825 Common Stock
Mar 10 2021	BUY Exercise of conversion of derivative security	-	2,025 Added 9.44%	19,434 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$13,256 $67.29 p/Share	197 Reduced 1.12%	17,409 Common Stock
Feb 10 2021	BUY Exercise of conversion of derivative security	-	778 Added 4.23%	17,606 Common Stock
Feb 06 2021	SELL Payment of exercise price or tax liability	$36,489 $68.46 p/Share	533 Reduced 3.07%	16,828 Common Stock
Feb 06 2021	BUY Exercise of conversion of derivative security	-	1,866 Added 9.71%	17,361 Common Stock
Jan 26 2021	BUY Grant, award, or other acquisition	-	1,294 Added 7.71%	15,495 Common Stock
Nov 10 2020	SELL Payment of exercise price or tax liability	$37,039 $60.62 p/Share	611 Reduced 4.13%	14,201 Common Stock
Nov 10 2020	BUY Exercise of conversion of derivative security	-	1,430 Added 8.8%	14,812 Common Stock
Aug 10 2020	SELL Payment of exercise price or tax liability	$94,817 $68.51 p/Share	1,384 Reduced 9.37%	13,382 Common Stock
Aug 10 2020	BUY Exercise of conversion of derivative security	-	3,345 Added 18.47%	14,766 Common Stock
May 04 2020	SELL Open market or private sale	$982,223 $80.09 p/Share	12,264 Reduced 51.78%	11,421 Common Stock
May 04 2020	BUY Exercise of conversion of derivative security	$762,210 $66.36 p/Share	11,486 Added 32.66%	23,685 Common Stock
Mar 10 2020	SELL Payment of exercise price or tax liability	$37,906 $72.34 p/Share	524 Reduced 4.12%	12,199 Common Stock
Mar 10 2020	BUY Exercise of conversion of derivative security	-	1,865 Added 12.78%	12,723 Common Stock
Feb 15 2020	BUY Grant, award, or other acquisition	$14,168 $53.67 p/Share	264 Added 2.37%	10,858 Common Stock

Also insider at

IMPL

IMPEL PHARMACEUTICALS INC Healthcare

DEW

Diane E. Wilfong

Interim Corp Controller & CAO

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Value

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

Operation

Value

Type

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD

Account